Not Yet RecruitingNot Applicable

Development of a Mobile Application Called TansiyoRitim for Hypertension Patients

Turkey (Türkiye)160 participantsStarted 2026-07-01

Plain-language summary

Based on King's Theory of Goal Success, this project is designed to develop a mobile application called TansiyoRitim for individuals over the age of 18 diagnosed with hypertension. The research consists of the following phases: creating educational content, designing the mobile application, and evaluating the application and its effectiveness. Within the scope of the research, participants' blood pressure control, self-efficacy levels, and treatment adherence behaviors will be assessed using valid and reliable measurement tools, and the goal is to support these behaviors through the developed mobile health application. Participants' clinical treatment processes, pharmacological treatment adjustments planned by the physician, and changes in medication dosages will be excluded from the scope of the project. No intervention will be made in the medical treatment currently being administered during the study; participants' routine clinical follow-up and treatment processes will continue within the framework of standard care. Only educational and mobile app-based supportive interventions will be implemented within the scope of the research.

Who can participate

Age range

18 Years – 85 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Diagnosed with hypertension at least 1 year prior to enrollment * Currently using antihypertensive medication * Able to use a smartphone * Able to measure blood pressure at home * No severe visual or hearing impairment * Able to communicate in Turkish * Literate * Willing to participate and provide informed consent Exclusion Criteria: * Age under 18 or over 85 years * Presence of severe comorbid chronic disease affecting participation * Severe physical or cognitive impairment preventing participation * Body mass index (BMI) ≥ 30 kg/m²

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Demographic Information Form

Timeframe: At baseline

Blood Pressure Measurement and Monitoring Form

Timeframe: From baseline to Month 3

Hill-Bone Hypertension Treatment Adherence Scale (HBHTTUÖ)

Timeframe: Baseline and Month 3

Hypertension Self-Efficacy Scale

Timeframe: Baseline and Month 3

Trial details

NCT IDNCT07556419

SponsorKafkas University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-10-30

Contact for this trial

Rabia Bayrambey, 1

+905059809499 rabia_byrmby36@outlook.com

View on ClinicalTrials.gov More Hypertension trials